Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans

被引:29
作者
Casu, B [1 ]
Naggi, A [1 ]
Torri, G [1 ]
机构
[1] Inst Chem & Biochem Res, I-20133 Milan, Italy
关键词
glycosaminoglycans; sulfation/desulfation; glycol splitting; structure-activity relationships;
D O I
10.1055/s-2002-34302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sulfated glycosaminoglycans (GAGS) are amenable to a number of chemical modifications that modulate their biological activity. N-sulfate groups can be exposed and N-acylated (usually N-acetylated), specific O-sulfate groups can be removed, and free hydroxyl groups (either preexisting in the original GAG or exposed by desulfation) can be sulfated. Heparin/heparan sulfate, chondroitin sulfate, and dermatan sulfate have been variously desulfated or sulfated to afford novel GAGs with protein binding and associated biological properties different from those of the original GAGS. Regiospecific sulfation of N-acetyl heparosan (E. coli K5 polysaccharide) afforded a number of derivatives, some endowed with antithrombotic activity and others with antimetastatic properties. Most of the activities could be correlated with typical sulfation patterns along each GAG backbone. Glycol splitting of nonsulfated glucuronic residues (including a critical residue in the pentasaccharide sequence of the active site for antithrombin) leads to substantial loss of anticoagulant activity of heparin. Partial removal of sulfate groups at position 2 of iduronic acid residues followed by glycol splitting of all nonsulfated uronic acid residues afforded nonanticoagulant, antiangiogenic hepatitis.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 54 条
  • [1] BISIO A, 1991, P 3 IT CARB S GRAD, V86
  • [2] HEPARIN-LIKE COMPOUNDS PREPARED BY CHEMICAL MODIFICATION OF CAPSULAR POLYSACCHARIDE FROM ESCHERICHIA-COLI K5
    CASU, B
    GRAZIOLI, G
    RAZI, N
    GUERRINI, M
    NAGGI, A
    TORRI, G
    ORESTE, P
    TURSI, F
    ZOPPETTI, G
    LINDAHL, U
    [J]. CARBOHYDRATE RESEARCH, 1994, 263 (02) : 271 - 284
  • [3] Casu B, 1996, NONANTICOAGULANT ACTIONS OF GLYCOSAMINOGLYCANS, P89
  • [4] Structure and biological interactions of heparin and heparan sulfate
    Casu, B
    Lindahl, U
    [J]. ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 : 159 - 206
  • [5] CONFORMATIONAL FLEXIBILITY - A NEW CONCEPT FOR EXPLAINING BINDING AND BIOLOGICAL PROPERTIES OF IDURONIC ACID-CONTAINING GLYCOSAMINOGLYCANS
    CASU, B
    PETITOU, M
    PROVASOLI, M
    SINAY, P
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1988, 13 (06) : 221 - 225
  • [6] STRUCTURE AND BIOLOGICAL-ACTIVITY OF HEPARIN
    CASU, B
    [J]. ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1985, 43 : 51 - 134
  • [7] Casu B., 1994, CARBOHYDR LETT, V1, P107
  • [8] CASU B, 1990, NEW TRENDS HAEMOSTAS, P2
  • [9] CASU B, 1999, ARZNEIM FORSCH DRUG, V46, P472
  • [10] CASU B, 2002, IN PRESS BIOCHEMISTR